• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

有机磷农药通过抑制青少年雄性大鼠大脑内源性大麻素水解酶诱导 ADHD 样行为。

Organophosphate Agent Induces ADHD-Like Behaviors via Inhibition of Brain Endocannabinoid-Hydrolyzing Enzyme(s) in Adolescent Male Rats.

机构信息

Department of Occupational and Environmental Health , Nagoya City University Graduate School of Medical Sciences , Nagoya 467-8601 , Japan.

Department of Chemistry, Faculty of Life Sciences , Tokyo University of Agriculture , Setakaya , Tokyo 156-8502 , Japan.

出版信息

J Agric Food Chem. 2020 Feb 26;68(8):2547-2553. doi: 10.1021/acs.jafc.9b08195. Epub 2020 Feb 13.

DOI:10.1021/acs.jafc.9b08195
PMID:31995978
Abstract

Anticholinergic organophosphate (OP) agents act on the diverse serine hydrolases, thereby revealing unexpected biological effects. Epidemiological studies indicate a relationship between the OP exposure and development of attention-deficit/hyperactivity disorder (ADHD)-like symptoms, whereas no plausible mechanism for the OP-induced ADHD has been established. The present investigation employs ethyl octylphosphonofluoridate (EOPF) as an OP-probe, which is an extremely potent inhibitor of endocannabinoid (EC, anandamide and 2-arachidonoylglycerol)-hydrolyzing enzymes: that is, fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL). An ex vivo experiment shows that EOPF treatment decreases FAAH and MAGL activities and conversely increases EC levels in the rat brain. Subsequently, EOPF (treated intraperitoneally once at 0, 1, 2, or 3 mg/kg) clearly induces ADHD-like behaviors (in elevated plus-maze test) in both Wistar and spontaneously hypertensive rats. The EOPF-induced behaviors are reduced by a concomitant administration of cannabinoid receptor inverse agonist SLV-319. Accordingly, the EC system is a feasible target for OP-caused ADHD-like behaviors in adolescent rats.

摘要

拟胆碱能有机磷 (OP) 类药物作用于多种丝氨酸水解酶,从而揭示出意想不到的生物学效应。 流行病学研究表明,OP 暴露与注意力缺陷/多动障碍 (ADHD) 样症状的发展之间存在关系,而尚未建立 OP 诱导 ADHD 的合理机制。 本研究采用乙基辛基膦酸氟化物 (EOPF) 作为 OP 探针,它是内源性大麻素 (EC,大麻素和 2-花生四烯酰甘油) 水解酶的极其有效的抑制剂:即脂肪酸酰胺水解酶 (FAAH) 和单酰基甘油脂肪酶 (MAGL)。 一项离体实验表明,EOPF 处理降低了大鼠脑中 FAAH 和 MAGL 的活性,而 EC 水平则相反增加。 随后,EOPF(在 0、1、2 或 3 mg/kg 时一次性腹膜内给药)在 Wistar 和自发性高血压大鼠中均明显诱导出 ADHD 样行为(高架十字迷宫测试)。 大麻素受体反向激动剂 SLV-319 的伴随给药可降低 EOPF 诱导的行为。 因此,EC 系统是青春期大鼠 OP 引起的 ADHD 样行为的可行靶标。

相似文献

1
Organophosphate Agent Induces ADHD-Like Behaviors via Inhibition of Brain Endocannabinoid-Hydrolyzing Enzyme(s) in Adolescent Male Rats.有机磷农药通过抑制青少年雄性大鼠大脑内源性大麻素水解酶诱导 ADHD 样行为。
J Agric Food Chem. 2020 Feb 26;68(8):2547-2553. doi: 10.1021/acs.jafc.9b08195. Epub 2020 Feb 13.
2
Organophosphate agents induce plasma hypertriglyceridemia in mouse via single or dual inhibition of the endocannabinoid hydrolyzing enzyme(s).有机磷酸酯类化合物通过单一或双重抑制内源性大麻素水解酶诱导小鼠血浆高甘油三酯血症。
Toxicol Lett. 2014 Feb 10;225(1):153-7. doi: 10.1016/j.toxlet.2013.12.004. Epub 2013 Dec 17.
3
Organophosphate agent action at the fatty acid amide hydrolase enhancing anandamide-induced apoptosis in NG108-15 cells.有机磷化合物作用于脂肪酸酰胺水解酶增强了大麻素诱导的 NG108-15 细胞凋亡。
J Toxicol Sci. 2023;48(7):421-428. doi: 10.2131/jts.48.421.
4
Distinct Activity of Endocannabinoid-Hydrolyzing Enzymes MAGL and FAAH in Key Regions of Peripheral and Central Nervous System Implicated in Migraine.在外周和中枢神经系统的偏头痛相关关键区域中,大麻素水解酶 MAGL 和 FAAH 的活性不同。
Int J Mol Sci. 2021 Jan 26;22(3):1204. doi: 10.3390/ijms22031204.
5
Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB receptor-mediated discriminative stimulus in mice.抑制内源性大麻素调节酶单酰基甘油脂肪酶会在小鼠中引发 CB 受体介导的辨别性刺激。
Neuropharmacology. 2017 Oct;125:80-86. doi: 10.1016/j.neuropharm.2017.06.032. Epub 2017 Jun 30.
6
Monoacylglycerol lipase inhibition by organophosphorus compounds leads to elevation of brain 2-arachidonoylglycerol and the associated hypomotility in mice.有机磷化合物对单酰甘油脂肪酶的抑制作用会导致小鼠脑内2-花生四烯酸甘油酯升高及相关的运动能力减退。
Toxicol Appl Pharmacol. 2006 Feb 15;211(1):78-83. doi: 10.1016/j.taap.2005.10.007. Epub 2005 Nov 28.
7
Endocannabinoid degradation inhibitors ameliorate neuronal and synaptic alterations following traumatic brain injury.内源性大麻素降解抑制剂改善创伤性脑损伤后的神经元和突触改变。
J Neurophysiol. 2020 Feb 1;123(2):707-717. doi: 10.1152/jn.00570.2019. Epub 2020 Jan 8.
8
Inhibition of monoacylglycerol lipase and fatty acid amide hydrolase by analogues of 2-arachidonoylglycerol.2-花生四烯酸甘油酯类似物对单酰甘油脂肪酶和脂肪酸酰胺水解酶的抑制作用
Br J Pharmacol. 2004 Nov;143(6):774-84. doi: 10.1038/sj.bjp.0705948. Epub 2004 Oct 18.
9
Fatty acid amide hydrolase inhibition by neurotoxic organophosphorus pesticides.神经毒性有机磷农药对脂肪酸酰胺水解酶的抑制作用。
Toxicol Appl Pharmacol. 2001 May 15;173(1):48-55. doi: 10.1006/taap.2001.9175.
10
Effects of fatty acid amide hydrolase (FAAH) inhibitors on working memory in rats.脂肪酸酰胺水解酶(FAAH)抑制剂对大鼠工作记忆的影响。
Psychopharmacology (Berl). 2016 May;233(10):1879-88. doi: 10.1007/s00213-015-4140-6. Epub 2015 Nov 12.

引用本文的文献

1
The endocannabinoidome-gut microbiome-brain axis as a novel therapeutic target for autism spectrum disorder.内源性大麻素系统-肠道微生物群-脑轴作为自闭症谱系障碍的新型治疗靶点。
J Biomed Sci. 2025 Jul 2;32(1):60. doi: 10.1186/s12929-025-01145-7.
2
Molecular Alterations of the Endocannabinoid System in Psychiatric Disorders.精神疾病中环核苷酸系统的分子改变。
Int J Mol Sci. 2022 Apr 26;23(9):4764. doi: 10.3390/ijms23094764.
3
Exposome of attention deficit hyperactivity disorder in Taiwanese children: exploring risks of endocrine-disrupting chemicals.
台湾地区儿童注意缺陷多动障碍的暴露组学研究:探讨内分泌干扰化学物质的风险
J Expo Sci Environ Epidemiol. 2022 Jan;32(1):169-176. doi: 10.1038/s41370-021-00370-0. Epub 2021 Jul 15.
4
The endocannabinoidome as a substrate for noneuphoric phytocannabinoid action and gut microbiome dysfunction in neuropsychiatric disorders
.神经精神疾病中外源大麻素作用于非愉悦性内源性大麻素系统和肠道微生物组功能障碍的基础研究。
Dialogues Clin Neurosci. 2020 Sep;22(3):259-269. doi: 10.31887/DCNS.2020.22.3/vdimarzo.